Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ascendis Health's Total Stockholders Equity for the quarter that ended in Jun. 2023 was R563 Mil. Ascendis Health's Total Assets for the quarter that ended in Jun. 2023 was R971 Mil.
Therefore, Ascendis Health's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.58.
The historical rank and industry rank for Ascendis Health's Equity-to-Asset or its related term are showing as below:
JSE:ASC's Equity-to-Asset is not ranked *
in the Medical Distribution industry.
Industry Median: 0.39 * Ranked among companies with meaningful Equity-to-Asset only.
Ascendis Health (JSE:ASC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Ascendis Health Equity-to-Asset Related Terms
Ascendis Health Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Ascendis Health's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ASC vs PHBI, GCAN, SGBI: Equity-to-Asset Comparison
For the Medical Distribution subindustry, Ascendis Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Health Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ascendis Health's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Ascendis Health's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Ascendis Health's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Health (JSE:ASC) has a Equity-to-Asset of 0.58 as of Jun. 2023. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ascendis Health and its competitors.
Is Ascendis Health's Equity-to-Asset too high?
Ascendis Health's current Equity-to-Asset is 0.58. The Medical Distribution industry median Equity-to-Asset is 0.39. Ascendis Health's value of 0.58 is 48.7% above this industry median. Overall, Ascendis Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Health's Equity-to-Asset compare to PHBI and GCAN?
Ascendis Health's Equity-to-Asset of 0.58 can be compared against companies in the Medical Distribution industry. The industry median Equity-to-Asset is 0.39. Ascendis Health's value of 0.58 is 48.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.39, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascendis Health's current Equity-to-Asset of 0.58 is 48.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ascendis Health and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascendis Health's current Equity-to-Asset is 0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Health stock overvalued right now?
Ascendis Health (JSE:ASC) has a current Equity-to-Asset of 0.58. The current Equity-to-Asset is 0.58 and 48.7% above the Medical Distribution industry median of 0.39. Ascendis Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Ascendis Health (JSE:ASC), the current Equity-to-Asset is 0.58 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ascendis Health Ltd is a health and wellness investment holding Company that holds investments in a number of companies that market and distribute a portfolio of brands, products, and medical devices. The company operates in two segments: i) Consumer Health (wellness, health supplements, speciality ingredients and compounded medicines) and ii) Medical Devices (distributor of medical devices, in vitro diagnostic products and orthopaedic equipment). The company generates the majority of its revenue from the Medical Devices segment.
11GF Score
Get the complete analysis for JSE:ASC
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ASC has been successfully added to your 
